Overview

Tumor Gene Expression in Women With Ovarian Cancer

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The study objective is to compare changes in expression of glucocorticoid-induced genes that may be involved in cell survival signaling in the tumors of ovarian cancer patients before and after an intraoperative dose of 20mg dexamethasone.
Phase:
Phase 4
Details
Lead Sponsor:
University of Chicago
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate